Fetching financial data...

Align Technology, Inc.

Data period: Annual Quarterly Graham uses annual
NASDAQ · Healthcare
Align Technology, Inc.
ALGN · Medical Instruments & Supplies
$172.89
▲ 3.73 (2.21%)
Cached · 10 min
Overall Grade
C
Defensive
A
Enterprising
Profitability
N/A
Fin. Health
A
Years to Pay Off Debt 1.0 yrs
Working Capital vs Long-Term Debt $666M
Working Capital $750M
Valuation
F
Margin of Safety 0.0%
Price-to-Book 2.98x
Cash Flow
B
Free Cash Flow $120M
CapEx % of Net Income 27.3%
Owner Earnings $200M
About Align Technology, Inc.
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Metric Explanations
What each dimension measures and where the thresholds come from.
Years to Pay Off Debt
Total Debt ÷ Net Income. Lower = stronger balance sheet. Important caveat: utilities, telecoms, REITs, and infrastructure companies carry large structural debt by design — their bond-like cash flows service it comfortably at ratios that would alarm Graham. Compare within sector.
Working Capital vs Long-Term Debt
Working Capital minus Long-Term Debt. Negative results are common and expected in capital-return-focused businesses like Apple, Domino's, and McDonald's — where aggressive buybacks and dividends intentionally reduce book equity. This does not indicate financial distress in high-FCF businesses.
Working Capital
Current Assets minus Current Liabilities. Negative working capital can be a deliberate efficiency strategy in businesses that collect cash before paying suppliers (retailers, fast food franchises, subscription businesses). Assess alongside free cash flow generation for full context.
Margin of Safety
How far below the Graham Number the stock trades. Graham required a 33% discount as a buffer against analytical error. However, the Graham Number itself assumes 1960s-era P/E and P/B norms — for modern asset-light businesses it often understates true intrinsic value, making 0% MoS appear misleadingly bad.
Price-to-Book
Market price vs book value per share. Rarely below 1.5x for quality businesses today. Intangible assets (brand, software, patents) don't appear on the balance sheet under accounting rules, making P/B artificially high for asset-light companies like software and consumer brands.
Free Cash Flow
Operating cash flow minus capital expenditures. Buffett's most important metric — cash a business actually generates for its owners after maintaining and growing its asset base. Consistently positive FCF is one of the strongest indicators of a durable, well-run business regardless of accounting profits.
CapEx % of Net Income
Capital expenditure as a share of net income. Low CapEx signals a capital-light business that doesn't need heavy reinvestment to sustain earnings — Buffett's ideal. High CapEx is structurally necessary in manufacturing, airlines, telecoms, and semiconductors. For these industries, a high reading reflects the business model, not poor management.
Owner Earnings
Net Income + Depreciation & Amortisation − Capital Expenditures. Buffett's preferred measure of a company's true annual earning power — what could theoretically be distributed to owners without impairing the business. More reliable than reported EPS because it accounts for the capital cost of maintaining the business.
Market Cap $12.4B
Enterprise Value $11.1B
P/E (TTM) 29.96
Dividend Yield N/A
Exchange NASDAQ
Gross Profit N/A
Operating Margin N/A
Net Margin N/A
Sector Healthcare
Industry Medical Instruments & Supplies
Employees 20290
Country United States
📖
Full Graham Analysis

Mr. Market is currently offering Align Technology, Inc. at $172.89.

The business passes only 0 of 6 of Graham's defensive criteria — well below his required standard.

At $172.89, the stock trades at a 290% premium to its Graham Number of $44.37. Graham would consider this price speculative.

There is no margin of safety at the current price. Graham would advise patience and waiting for a better entry point.

Trading at 25.2x NCAV. Expected for most quality businesses — NCAV was designed to find depression-era bargains and rarely applies to modern profitable companies..

Conclusion: By Graham's standards, this stock is speculative at its current price. The intelligent investor would look elsewhere or wait.

Showing Key Metrics
Income Highlights
Metric Q2 2026 Q4 2025 Q4 2024
Gross Profit % N/A 65.3% N/A
Operating Margin % N/A 15.2% N/A
Net Income % N/A 13.0% N/A
Diluted EPS 1.51 1.89 N/A
Balance Sheet Highlights
Metric Q1 2026 Q4 2025 Q4 2024
Total Assets $6.3B $6.2B N/A
Total Debt $116M $114M N/A
Working Capital $750M $697M N/A
Years to Pay Debt 1.03 0.84 N/A
Cash Flow Highlights
Metric Q1 2026 Q4 2025 Q4 2024
Free Cash Flow $120M $187M N/A
Owner Earnings $200M $274M N/A
CapEx % of Net Income 27.3% 26.5% N/A
📊 Quarterly mode — Graham Fair Value & 7 Criteria require annual data. Switch to Annual for full analysis.
Quarterly Health Checks
3 Graham/Buffett criteria that are valid and reliable on quarterly data
❌ Financial Condition
Current assets vs current liabilities — a real-time liquidity snapshot. Valid and reliable on quarterly data.
1.39x current ratio
vs ≥ 2.0x
✅ Free Cash Flow
Buffett's most important single metric. A positive FCF quarter means the business generated real cash for owners after maintaining its asset base.
$120M
vs Positive
Operating Cash Flow
$151M
Latest quarter · Buffett's cash reality check
ROIC
nan%
Based on latest annual operating income
Return on Invested Capital — Buffett's preferred measure for asset-light businesses. ROIC > 15% consistently signals a durable competitive advantage (moat). More meaningful than P/B for software, pharma, and consumer brand companies where most value is intangible and off-balance-sheet.
Market Cap / Net Assets
3.0x
Net Assets: $4.1B
Peers & Industry
No auto-detected peers for Medical Instruments & Supplies. You can manually compare ALGN against any stock using the Compare tool.
"The management of a business is its most important single factor — more important than market position, patents, or financial structure."
— Benjamin Graham
Capital Allocation & Alignment
Insider Ownership
6.82%
Moderate — some alignment with shareholders
Share Buybacks (Latest Year)
$466M
Management is returning capital to shareholders via buybacks
Debt Trend YoY
+1.4% YoY
Debt is roughly stable
Leadership Team
Joseph Hogan
President, CEO & Director
Age 68
Pay: $2,637,116
John Morici
CFO & Executive VP of Global Finance
Age 58
Pay: $1,024,500
Top Institutional Holders
Institution % Owned Shares
Vanguard Capital Management LLC 6.13% 4,389,119
Blackrock Inc. 5.99% 4,289,924
Capital World Investors 5.69% 4,072,296
Capital International Investors 5.32% 3,809,202
Vanguard Portfolio Management LLC 4.40% 3,150,783
FMR, LLC 3.77% 2,700,359
State Street Corporation 3.51% 2,516,254
Ninety One UK Ltd 3.09% 2,209,791
Risk Analysis
Beta (Market Risk)
1.65
High volatility — moves more than the market
Short Interest
7.7% of float
Moderate short interest
Debt-to-Equity
0.02x
Conservative balance sheet — low financial risk
Current Ratio
1.40x
Adequate liquidity
52-Week Price Range
Low: $122.00 Current: $172.89 High: $200.44
Currently at 65% of 52-week range

Align Technology, Inc. (ALGN) fundamental analysis — Overall grade C based on profitability, financial health, valuation and cash flow. Graham's Fair Value: $44.37. Margin of safety: 0%. Gross profit margin: N/A. Operating margin: N/A. Net margin: N/A. Market cap: $12.4B. Sector: Healthcare. Industry: Medical Instruments & Supplies. Analysis powered by 360investing — free fundamental stock analysis based on Benjamin Graham and Warren Buffett principles.

Disclaimer: 360investing is provided for informational and educational purposes only and does not constitute financial, investment, legal, or tax advice. All data is sourced from public third-party providers and may be delayed, inaccurate, or incomplete. Past performance is not indicative of future results. Analysis, scores, and valuations are algorithmic and do not represent professional investment recommendations. Always conduct your own due diligence and consult a qualified financial adviser before making any investment decision. Use of this tool constitutes acceptance that 360investing and its operators bear no liability for decisions made based on information presented here.

Data Sources & Methodology Privacy Policy